← Return to Just approved: Evusheld for the pre-exposure prevention of COVID-19
DiscussionJust approved: Evusheld for the pre-exposure prevention of COVID-19
Transplants | Last Active: Aug 19, 2022 | Replies (173)Comment receiving replies
Replies to "https://www.nytimes.com/2021/12/08/business/fda-authorizes-astrazeneca-drug-immunocompromised.html https://thenyledger.com/business/the-f-d-a-authorizes-astrazeneca-drug-to-protect-people-with-immune-problems/ Haven’t seen much else yet, but I expect there will be more soon in..."
It is not helpful. NYT can't see unless you have a subscription. Other article says not found